BioCardia, Inc. financial data

Symbol
BCDA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
320 Soquel Way, Sunnyvale, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Tiger X Medical, Inc. (to 10/17/2016), Cardo Medical, Inc. (to 5/25/2011), CLICKNSETTLE COM INC (to 10/20/2008), NAM CORP (to 3/29/2000)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 42.5 % -74.7%
Debt-to-equity -289 % -281%
Return On Equity 527 %
Return On Assets -278 % -73.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.12M shares -90.2%
Common Stock, Shares, Outstanding 2.12M shares -90.2%
Entity Public Float 48M USD +142%
Common Stock, Value, Issued 2K USD -90.9%
Weighted Average Number of Shares Outstanding, Basic 1.88M shares +38.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 5.07M USD -43.9%
Costs and Expenses 9.03M USD -32.9%
Operating Income (Loss) -8.61M USD +34%
Nonoperating Income (Expense) 47K USD +56.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -8.56M USD +34.2%
Earnings Per Share, Basic 1.17 USD/shares +65.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.42M USD -67%
Accounts Receivable, after Allowance for Credit Loss, Current 10K USD -91.3%
Assets, Current 1.57M USD -66.2%
Property, Plant and Equipment, Net 61K USD -56.1%
Operating Lease, Right-of-Use Asset 1.09M USD -24.1%
Other Assets, Noncurrent 171K USD 0%
Assets 2.89M USD -54.8%
Accounts Payable, Current 1.45M USD +111%
Accrued Liabilities, Current 4K USD -96.4%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 4.07M USD +12.6%
Operating Lease, Liability, Noncurrent 780K USD -31.5%
Liabilities 4.85M USD +2.04%
Retained Earnings (Accumulated Deficit) -156M USD -5.8%
Stockholders' Equity Attributable to Parent -1.96M USD -220%
Liabilities and Equity 2.89M USD -54.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.53M USD +40.2%
Net Cash Provided by (Used in) Financing Activities 1.38M USD +2050%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 50M shares -50%
Common Stock, Shares, Issued 2.12M shares -90.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -154K USD +93.9%
Deferred Tax Assets, Valuation Allowance 36.7M USD +8.03%
Deferred Tax Assets, Gross 36.7M USD +8.03%
Operating Lease, Liability 1.14M USD -23%
Depreciation 77K USD -12.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.3M USD -26.9%
Property, Plant and Equipment, Gross 791K USD -1.25%
Operating Lease, Liability, Current 358K USD +5.29%
Lessee, Operating Lease, Liability, to be Paid, Year Two 514K USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 499K USD +2.89%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 161K USD -46.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 44K USD -91.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 1.68M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 44K USD -91.4%
Operating Lease, Payments 321K USD +7%
Additional Paid in Capital 154M USD +3.34%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 19K USD -13.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 823K USD -28.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%